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651. Current literature highlights
1.1. Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular
chaperone
Molecular chaperones are protein machines that are responsi-
ble for the correct folding, stabilisation and function of other pro-
teins in the cell. One of the most studied amongst the multitude
of molecular chaperones and co-chaperones identiﬁed is heat
shock protein 90 (Hsp90). Hsp90 is a 90 kDa ATP-dependent pro-
tein, and has multiple client proteins involved in the development
and progression of cancer. The client proteins rely on Hsp90 for
their proper folding, and thus Hsp90 has been the focus of interest
as a potential anticancer drug target.
A number of natural product (e.g. geldanamycin (1)) and semi-
synthetic analogues have entered clinical trials as Hsp90 inhibitors.
However, there are issues with compounds that have entered clin-
ical trials to date, as these compounds have potential therapeutic
limitations because of low solubility, liver toxicity, and extensive
metabolism. In an effort to obviate these problems, recent work
has disclosed research into the identiﬁcation of non-quinone-con-
taining small molecule inhibitors of Hsp90 chaperone activity1.O
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2   R = NHCH2CH2CH3This new research employed a high throughput screening cam-
paign using a competitive binding assay, in which the ability of test
compounds under study to displace tritium-labelled 17-propyla-
minobenzoquinone ansamycin (2) from Hsp90 was assessed. The
ﬁrst compound of interest to arise out of this work was 3, which
although potent in the competitive binding assay (Ki = 200 nM),
was unfortunately not potent (IC50 > 20 lM) in a cell-based assay
measuring the degradation of the Hsp90 client protein Akt.
To move the project forward, these researchers obtained a 1.4 Å
co-crystal structure of compound 3 bound to Hsp90 and compared
it to the crystal structures of other known Hsp90 inhibitorsEmail-address: nterrett@ensemblediscovery.com
doi:10.1016/j.comche.2009.05.001complexed with the protein. This led to the discovery that only
two of the three hydroxyl groups on 3make key hydrogen bonding
interactions with conserved water molecules. Thus, there existed
the possibility of replacing a hydroxyl moiety with other groups
that could modulate not only cell-based potency, but also physico-
chemical properties. To this end, the researchers designed a small
library in which commercially available amines were used to
replace the pyrrole moiety present in inhibitor 3, as well as dispen-
sing with one hydroxyl group in favour of a hydrogen atom.
After synthesis and biological screening, it was found that li-
brary compounds derived from primary amines were less potent
Hsp90 inhibitors than those prepared from secondary amines.
One of the most potent compounds isolated at this stage of the re-
search program was 4 which possessed a cell-based potency of 9.3
lM. In order to further improve inhibitor potency, compound 4
was resolved by preparative chiral supercritical ﬂuid chromatogra-
phy to obtain single enantiomers. Of these, compound 5 was the
more potent and displayed a Ki of 30 nM. Further medicinal chem-
istry design and parallel synthesis based around analysis of X-ray
co-crystals, led to the discovery of compound 6 which possessed
a Ki of <10 nM and a cell-based potency of 20 nM.
1.2. Evaluation of N-aryl L-homoserine lactones reveals a new set of
quorum sensing modulators
Bacteria often assemble into multicellular communities and in-
itiate processes as a group that they are incapable of doing as indi-
22 N. K. Terrerr / Combinatorial Chemistry - An Online Journal 11 (2009) 21–23vidual cells. These group behaviours, such as virulence factor pro-
duction and bioﬁlm formation, are under the control of quorum
sensing cell–cell signalling mechanisms, and these play a signiﬁ-
cant role in the establishment of both symbiotic and pathogenic re-
lationships with eukaryotic hosts.
Quorum sensing is mediated by lowmolecular weight autoindu-
cers and their cognateprotein receptors. Autoinducer–receptorbind-
ing occurs once the bacteria reach a threshold cell density, and this
binding event controls the transcription of genes necessary for bac-
terial group functions. Interception of this binding event represents
a strategy to attenuate bacterial group behaviours, andhas thus been
considered as an approach to the control of bacteria. Recentwork has
disclosed the creation of a set of autoinducermimics that are derived
from earlier disclosed compounds of general structure (7)2.O
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7Subtle structural changes in the R group in structure 7 has been
shown to have a marked effect on ligand activity. In designing and
synthesising a solution phase, microwave-assisted, library of deriva-
tives of 7, various spacers and heteroatomswere incorporatedwithin
the R group to generate awide diversity of substituents and thus SAR.
The compounds from this library were evaluated for both an-
tagonistic and agonistic activity against LuxR-type receptors in A.
tumefaciens, P. aeruginosa, and V. ﬁscheri (TraR, LasR, and LuxR,
respectively), using cell-based reporter gene assays. LuxR activa-
tion or inhibition in the V. ﬁscheri strain was reported by luciferase
production. Antagonism assays were performed in the presence of
library compound and native N-acylated L-homoserine lactone
ligand (8–10) at its approximate EC50 value, while agonism assays
were performed with library compound alone. The native N-acy-
lated L-homoserine lactone ligands for A. tumefaciens (9), P. aerugi-
nosa (10), and V. ﬁscheri (8) were used as controls for these assays.O
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nBased on these assays, a number of active compounds were ob-
tained. One of the most potent compounds obtained was (11)
which possessed IC50 values of 0.44 lM, 2 lM and 1.9 lM against
A. tumefaciens TraR, E. coli LasR and V. ﬁscheri LuxR, respectively.O
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11Thus the disclosed library work has delivered a new set of syn-
thetic LuxR-type receptor antagonists and agonists, thus serving to
underscore the utility of screening focused N-acylated L-homoser-
ine lactone ligand libraries for the optimisation of existing, and the
identiﬁcation of new, LuxR-type receptor modulators.
2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A set of macrocycles has been generated by solid phase synth-
esis of linear trimers of 5-aminoacyl-3-aminomethyl-benzoatesfollowed by resin cleavage and solution phase macrocyclisation.
These scaffolds can serve as useful building blocks for molecular
recognition studies, especially where differentially functionalised
molecular platforms spanning large surface areas are required3.
2.2. Solution-phase synthesis
2-Amino-4-heteroarylpyrimidines have been synthesised bymi-
crowave-induced SNAr reactions of primary alkyl amines and 2-
methylsulphonylpyrimidines or 2-chloropyrimidines. Following
this methodology, pendant piperidine functionality was elaborated
using silica-bound reagents in microwave-assisted reductive ami-
nation and amide bond formation protocols. These methods proved
to be versatile, efﬁcient, and amenable to parallel synthesis4.
4,5-Disubstituted-3(2H)-pyridazinones have been initially
synthesised via sodium alkoxide additions to an advanced bromide
intermediate. A small parallel chemistry effort has resulted in a
poor success rate, and thus the reactivity of the reaction partner
was increased by performing a copper-catalyzed Finkelstein reac-
tion. A number of alternative syntheses of this series of compounds
have been described and these methods are versatile, efﬁcient, and
amenable to parallel synthesis5.2.3. Scaffolds and synthons for combinatorial libraries
No papers this month.
2.4. Solid-phase supported reagents
C2-symmetric bis(sulphonamide) ligands derived from chiral
trans-(1R,2R)-cyclohexane-1,2-diamine have been immobilised on
silica gel and on polystyrene resin, and complexed to RhIIICp. The
resulting complexes were used as catalysts in the asymmetric
transfer hydrogenation of acetophenone giving the chiral second-
ary alcohol product in high yields and enantioselectivities with
aqueous sodium formate as the hydride source6.
The synthesis of a-trimethylsilyldibutylallylstannane grafted
onto an insoluble macroporous polymer has been reported. This bi-
metallic reagent was treated with aldehydes in the presence of in-
dium trichloride to afford in good yields both symmetrical and
unsymmetrical cis-2,6-disubstituted dihydropyrans, practically
uncontaminated with organotin residues7.
The highly efﬁcient oxidative decarboxylation of carboxylic
acids with sodium periodate catalysed by a supported manganese
(III) porphyrin has been described. In the presence of manganese
(III) tetra(4-pyridyl)porphyrin supported on cross-linked chloro-
methylated polystyrene, [Mn(T4PyP)-CMP], as catalyst, carboxylic
acids were converted to their corresponding carbonyl compounds
via oxidative decarboxylation with sodium periodate using imida-
zole as axial ligand8.
2.5. Novel resins, linkers and techniques
Solid-support conjugation at the 5’-terminal primary amine of oli-
gonucleotides is a convenient and powerful method for introducing
various functional groups. However, conventional aliphatic amines
do not necessarily provide conjugates with sufﬁcient yields. To im-
prove the modiﬁcation efﬁcacy, the amino-linker (aminoethoxycar-
bonyl)aminohexyl group (ssH-linker), has been explored for solid-
support conjugation, and shown to be a useful terminal modiﬁcation
for the solid-support conjugation of functional molecules9.
2.6. Library applications
The successful application of libraries based on host–guest
inclusion complexes in cyclodextrins and cucurbiturils for the
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matic as well as linear and branched amines in water has been re-
ported. The main advantage of this approach is that an array made
by combining six simple basic dyes with seven commercial organic
capsules allows a perfect discrimination among 14 amines with
only very subtle structural differences10.
A homology model of the p110a catalytic subunit of PI3Ka has
been generated from the p110a crystal structure. Using this model,
an isonicotinic scaffold was designed for chemically exploring the
PI3Ka and a binding sites. A focussed library of derivatives was
synthesised and tested, and two morpholine acids proved to be
the most potent analogues11.
A highly ligand efﬁcient lead molecule has been rapidly devel-
oped into a DPP-IV selective candidate series using focussed small
library synthesis. A signiﬁcant hurdle for series advancement was
genetic safety since some agents in this series impaired chromo-
some division as detected using an in vitro micronucleus assay. Ad-
vanced proﬁling of a subset within this structural space identiﬁed a
compound with a clean safety proﬁle, an acceptable human DPP-IV
inhibition proﬁle based on the rat PK/PDmodel and a projected hu-
man dose that was suitable for clinical development12.
With the aim to discover novel HDAC inhibitors with high
potency and good safety proﬁles, a small library based on a N-hy-
droxy-(4-oxime)-cinnamide scaffold has been developed. The
synthesis of these novel compounds and some preliminary in vitro
cytotoxic activity on three tumor cell lines, NB4, H460 and HCT116,
as well as their inhibitory activity against class I, II and IV HDAC
has been reported13.
The C-cyclopropylalkylamide scaffold has been previously iden-
tiﬁed as a new structural framework for antiestrogens. A second
generation library provided three compounds that bind estrogen
receptor (ER)a, and further screening of this library identiﬁed an
ERb hit and inspired another round of SAR. A new focused library
was tested for binding to the ERs, and for effects on the growth
of breast cancer cell lines and protein levels of common cell cycle
regulators14.
Optimisation through parallel synthesis of a novel series of
hepatitis C virus (HCV) NS5B polymerase inhibitors has led to the
identiﬁcation of (R)-11-(4-benzyloxy-2-ﬂuorophenyl)-6-hydroxy-
3,3-dimethyl-10-(6-methylpyridine-2-carbonyl)-2,3,4,5,10,11-hexa-
hydro-dibenzo[b,e][1,4]diazepin-1-one and (R)-11-(4-benzyloxy-
2-ﬂuorophenyl)-6-hydroxy-3,3-dimethyl-10-(2,5-dimethyloxazol-
4-carbonyl)-2,3,4,5,10,11-hexahydro-dibenzo[b,e][1,4]diazepin-1-
one as potent (replicon EC50 = 400 nM and 270 nM, respectively)
and selective (CC50 >20 lM) inhibitors of HCV replication15.
Four enantiopure cytisine-inspired scaffolds have been accessed
via a versatile pyrrolidine template derived from a stereocontrolled
[3+2] azomethine ylide–alkene cycloaddition. Differential ester
protection allows for the selective formation of either a bridged bi-
cyclic or tricyclic scaffold via pyridone cyclization. Solid-phase di-
versiﬁcation of the pyridone scaffolds yielded a diverse library of
15,000 compounds enabling the discovery of a novel class of Bcl-
2 inhibitors16.
Starting from a non-selective pyrazolo-pyrimidone lead, the se-
quential use of parallel medicinal chemistry and directed synthesis
has led to the discovery of potent, highly selective, and orally bioa-
vailable PDE9 inhibitors. The availability of these tools allowed for
a thorough evaluation of the therapeutic potential of PDE9
inhibition17.
Diversity-oriented synthesis of furo[3,2-f]chromanes with anti-
mycobacterial activity has been investigated. A simple synthetic ac-
cess to related structures allowing the preparation of a diverse set of
analogues was developed. The biological evaluation of the effect of
these compounds on the growth of Mycobacterium bovis as well asMycobacterium tuberculosis pointed out a fourfold improvement of
the antimycobacterial properties for one of the compounds made18.
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